Acquired Hemolytic Anemias
Two Onc Docs
00:00
Key toxicities of echolizumab, new monoclonal antibodies, and other related syndromes
This chapter discusses the key toxicities associated with echolizumab, as well as alternative monoclonal antibodies such as ravilizumab and PEGSATAKOPLAN. They also touch on hereditary spherocytosis as a similar syndrome.
Transcript
Play full episode
